Wednesday, March 30, 2016

50% ...


... of the 341 employers surveyed by the Pharmacy Benefit Management Institute's 2016 Trends in Specialty Drug Benefits Report have formulary exclusions for growth hormones, followed by hepatitis C (47%), fertility (43%), cholesterol (37%) and multiple sclerosis (32%).

No comments:

Post a Comment